---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-22-000006"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T17:52:38.978866+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Founder and Executive Chairman Fuad El-Hibri to retire from Emergent BioSolutions effective April 1, 2022

## Summary
- Fuad El-Hibri, founder and executive chairman, will retire effective April 1, 2022, after 23 years.
- Retirement not due to any dispute with company, management, or board.
- He will remain available on advisory/consulting basis on terms to be agreed.
- Board expects to name new chair ahead of retirement date.
- Under his leadership, Emergent generated ~$1.6B revenue in 2020 and delivered over 120M dose-equivalents of COVID-19 vaccine.

## SEC filing metadata
- accession: 0001367644-22-000006
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000006/0001367644-22-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000006/ebs-20220113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-22-000006
- JSON: https://secwatch.observer/filing/0001367644-22-000006.json
- Plain text: https://secwatch.observer/filing/0001367644-22-000006.txt

## Key facts
- Executive change
  Fuad El-Hibri departed as Executive Chairman of the Board at Emergent BioSolutions Inc..
  - Action: retired and resigned
  - Role: Executive Chairman of the Board
  source text: On January 13, 2022, Fuad El-Hibri, Founder and Executive Chairman of the Board of Directors (the “Board”) of Emergent BioSolutions Inc. (the “Company”), notified the Company of his retirement and resignation as an officer, director and employee of the Company, effective as of April 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000006/0001367644-22-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.